Cancer Flashcards
Tumour antigens
Neoantigens (encoded by mutated genes)
Onncogenic virus antigens (EBV)
Overexpressed cell proteins
Elimination phase
tumour cells killed by NK/CD4/CD8 cells
Equilibrium phase
immune system is unable to destroy tumour (rate of destruction = rate of new cells)
Escape phase
clinically detectable tumour appears
Neutrophil immune surveillance (cancer)
produce TRAIL, stimulate apoptosis
NK cell immune surveillance (cancer)
express NKG2D which binds MICA and MICB on tumour cells, will also look for failure to express MHC
Macrophage immune surveillance (cancer)
M1 macrophages recognize DAMPs, get activated by T cell production of IFN-gamma, produce NO
CD8 immune surveillance (cancer)
looks for tumour peptides presented on MHC I, can lyse tumour cells
CD4 immune surveillance (cancer)
Activated by APCs presenting tumour antigens, produce IFN gamma to activate macrophages
NKT cell immune surveillance (cancer)
recognize antigen presented by non-classical MHC I by tumour
Cancer immunoediting
“natural selection” of tumours – by killing off any cells it can, the immune system selects for cancer cells that can evade immune system. This is how we get a tumour filled with only strong cells
Molecules that help tumour escape
TGF-beta, IDO, Galectin-1, PDL-1
How TGF-beta helps tumour escape
induces tumour proliferation, angiogenesis, suppresses host immunity
How IDO help tumour escape
Suppresses T cell proliferation
Galectin-1 tumour escape
stimulates angiogenesis